Jeuveau Guide: How “Newtox” Compares to Botox and Dysport

Jeuveau, sometimes marketed as “Newtox,” is the newest of the major FDA-approved neurotoxins for cosmetic use, joining Botox and Dysport as the third option commonly available in U.S. medical aesthetic practices. The product was approved in 2019 specifically for the treatment of moderate to severe glabellar lines (the frown lines between the eyebrows), and its position in the market has been carved out as a younger-feeling, sometimes more affordable alternative to Botox. The honest comparison is that Jeuveau is biochemically similar to Botox, produces similar results in similar timeframes, and competes primarily on pricing and brand positioning rather than on dramatically different clinical outcomes.

This Jeuveau guide walks through what the product actually is, how it compares clinically to Botox and Dysport, what specific situations make Jeuveau the right choice, what to expect from treatment, and how the pricing typically works. By the end you will understand where Jeuveau fits in the neurotoxin landscape and how to think about choosing between the available options.

Jeuveau Guide: What Jeuveau Actually Is

Jeuveau is the brand name for prabotulinumtoxinA, a botulinum toxin type A formulation manufactured by Evolus. It received FDA approval in 2019 specifically for the temporary improvement of moderate to severe glabellar lines (the frown lines between the eyebrows) in adults. The active toxin core is biochemically the same as Botox: both products work by blocking the nerve signal between specific muscles and the brain, which prevents those muscles from contracting fully. Without the muscle contraction, the skin overlying the muscle stops being repeatedly creased, and the targeted wrinkles soften over the days following treatment.

The differences between Jeuveau and Botox come down to manufacturing process, complexing proteins surrounding the active toxin, and brand positioning. The active mechanism is essentially identical, which is why most clinical comparisons find similar results in patient outcomes. According to the FDA, Jeuveau is approved for the same general indication as Botox Cosmetic for cosmetic use, with the approval based on clinical trials demonstrating equivalent safety and efficacy for the glabellar line indication.

Jeuveau vs Botox: The Real Differences

The differences between Jeuveau and Botox in cosmetic practice are smaller than marketing might suggest. Onset of effect is the most consistent clinical difference: most patients see initial Jeuveau effect within 2 to 3 days of treatment, while Botox typically takes 3 to 5 days to start showing results. Both products reach their full effect by day 14, so the difference is in the early timeline rather than the final outcome. For patients with specific events on a tight schedule, the slightly faster Jeuveau onset can be a useful planning advantage.

Duration is roughly comparable between the two products, with most patients experiencing 3 to 4 months of effect from cosmetic doses. Some patients find Jeuveau lasts marginally shorter than Botox, others find it lasts marginally longer, and the variation patient-to-patient is much larger than the average difference between the products. Individual response to either product is the dominant factor. Dosing is essentially equivalent on a unit-for-unit basis, unlike the 3-to-1 conversion needed when comparing Dysport to Botox. A clinic charging 25 units of Jeuveau for the glabella is dosing similarly to a clinic charging 25 units of Botox.

Jeuveau vs Dysport

Jeuveau and Dysport are both alternatives to Botox but differ from each other in important ways. Dysport is dosed in different units than Botox or Jeuveau, with approximately 3 units of Dysport equaling 1 unit of either Botox or Jeuveau in clinical effect. A Dysport quote will list a much larger unit count than a Jeuveau or Botox quote for the same area, even though the actual product activity is comparable. Dysport also has a slightly wider spread pattern from each injection site, which can be an advantage for broad areas like the forehead or a disadvantage for precision work near the eyes.

Jeuveau has a more focal injection pattern similar to Botox, which makes it the more appropriate choice when precision matters. For patients who have used Dysport and want to try a Botox-equivalent without switching to Botox specifically, Jeuveau is a reasonable alternative. For patients comparing prices across the three products, the calculation should account for the unit conversion: a Dysport quote with 75 units is treating the same area as a Jeuveau quote with 25 units, and the per-area cost is what matters for comparison rather than the per-unit price.

Why Jeuveau Costs Less Than Botox at Many Clinics

Jeuveau’s pricing position is one of its main competitive advantages in the U.S. market. The product is typically priced 10 to 20 percent lower than Botox at most clinics that offer both, which can produce meaningful savings for patients on regular maintenance schedules. The pricing difference reflects several factors including Evolus’s strategy as a newer market entrant pursuing market share, lower marketing budgets compared to Botox, and the typical market dynamic where newer competitive products price slightly below established market leaders.

For patients who get cosmetic Botox or equivalent on a quarterly maintenance schedule, the cumulative annual savings from choosing Jeuveau over Botox can run several hundred dollars depending on the unit count and per-unit pricing. For first-time patients evaluating which product to use, the cost difference is one factor but not necessarily the deciding one. Provider experience with the specific product, the clinic’s overall approach to cosmetic treatment, and the patient’s individual response patterns matter more than the per-unit price difference for most situations.

What Areas Jeuveau Treats

Jeuveau’s FDA approval is specifically for glabellar lines (the frown lines between the eyebrows), but in practice many providers use it off-label for the same areas commonly treated with Botox: forehead lines, crow’s feet, brow lift, lip flip, and other facial expression areas. Off-label use is common and accepted in cosmetic practice when the underlying mechanism (blocking specific muscle activity) is the same as the on-label indication. Patients pursuing Jeuveau for areas beyond the glabella should understand they are using an FDA-approved medication off-label, which is legally and clinically standard but worth knowing about.

For uses involving larger muscles like the masseter (jaw slimming or TMJ relief), Botox and Dysport have more extensive clinical literature and established off-label usage patterns. Jeuveau can be used for these applications as well, but providers experienced with masseter treatment may prefer the products with more established protocols. For typical upper-face cosmetic applications, Jeuveau performs equivalently to Botox in most clinical comparisons.

What to Expect From a Jeuveau Treatment

The Jeuveau appointment process is identical to a Botox appointment in most ways. The provider examines the treatment areas, discusses goals, marks the planned injection points, and administers the injections in sequence. Each injection is a brief pinch and pressure sensation, with the overall discomfort comparable to standard cosmetic injections. The total appointment typically takes 15 to 30 minutes from start to finish for a focused upper-face treatment.

Recovery is also similar to other neurotoxin treatments. Most patients return to normal activities immediately, with the standard restrictions for the first 4 to 24 hours: avoid lying down for 4 hours, skip strenuous exercise for 24 hours, avoid heat including saunas for the same window, and skip alcohol for the day. Pinpoint redness at injection sites fades within the hour. Small bruises (when they occur) are easily covered with concealer and resolve within a week. Initial effect appears at 2 to 3 days, with full effect by day 14.

Choosing Between Jeuveau, Botox, and Dysport

For most cosmetic patients in most situations, the three major neurotoxins (Botox, Dysport, and Jeuveau) produce comparable results, and the choice often comes down to provider experience, pricing, and patient preference rather than dramatic clinical differences. Patients who have used one product successfully and are happy with their results have no compelling reason to switch unless cost or product availability changes the calculation. Patients who are new to neurotoxins can choose based on factors including provider recommendation, pricing at their preferred clinic, and any specific product features that matter to them.

Specific situations may favor one product over another. Patients wanting the slightly faster onset of Jeuveau before a planned event may prefer it over Botox. Patients who tend to need the slightly faster onset of Dysport may prefer Dysport. Patients with strong loyalty to the established Botox brand based on prior experience may continue with Botox. Patients seeking the most affordable per-unit pricing may find Jeuveau or, accounting for the unit conversion, Dysport offers slight savings. Patient satisfaction tends to be high with all three products when matched to appropriate concerns and administered by trained providers.

Safety and Side Effects

Jeuveau has a safety profile comparable to other FDA-approved botulinum toxin products. Common side effects are local and minor: pinpoint redness at injection sites, occasional small bruises, mild headache for a day or two after treatment in some patients, and rare temporary brow ptosis (eyelid heaviness) when the forehead and brow injections affect adjacent muscles. The serious risks are rare and similar to those of Botox or Dysport, including the boxed warning about distant spread of toxin effect that applies to all botulinum toxin products.

Provider technique matters significantly for both safety and aesthetic outcomes. Skilled injectors with experience using the specific product produce more consistent results than providers who use the product occasionally. The conservative-dose approach common to natural-result Botox technique applies equally to Jeuveau, with starting doses calibrated to individual muscle anatomy and adjustments made at the two-week follow-up if needed. Patients evaluating Jeuveau should look for providers who use the product regularly rather than offering it occasionally as a discount alternative to Botox.

Medically Reviewed By

Dr. Ashar N., DNP, APRN, FNP-C, PMHNP-BC

Medical Director at Tactus Health. Dual board-certified nurse practitioner specializing in medical aesthetics, hormone optimization, and weight loss. In-person care in Sugar Hill, GA.